Committee On Designated Substances Considers Cannabinoid-Type Drugs In “Comprehensive Designation”
This article was originally published in PharmAsia News
The Pharmaceutical Affairs and Food Sanitation Council’s Committee on Designated Substances approved Nov. 28 a “comprehensive designation” system that would allow designated substances regulated by the Pharmaceutical Affairs Law and substances with similar chemical structures to be batched together.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”